Quantum-Math_vs Molecular_Biology? Rocket!! How_bout_our Cure_4_Cancer_Collaborator Tyme Technologies going to Phase2 in clinical studies?
Phase II/III Randomized Multi-Center Study of SM-88 in Patients with Pancreatic Cancer Whose Disease Has Progressed or Recurred Summary 10/11/2019NOTE: Enrollment in Part 1 is complete. Part 2 is actively enrolling. The purpose of this phase II/III study is to evaluate the safety and efficacy of SM-88 in patients with metastatic pancreatic cancer whose disease has progressed or recurred after two lines of prior systemic General Information NCT#: NCT03512756 Study ID: Tyme-88-Panc Trial Phase: Phase II
Trial Sponsor: Tyme, Inc. Therapies Used in This Trial: SM-88
On my rudimentary comparison of quantum to molecular science Rocket. quantum gets down to sub-atomic particals/physics. Thus, more numbers to play with.
Search on Pancreatic Cancer (PANCAN) witj Tyme Tech. See what you think. And GLTUA
CLINICAL TRIAL FINDER - PANCAN 10/11/2019 NOTE: Enrollment in Part 1 is complete. Part 2 is actively enrolling. [/quote]Rocket! Getting excited about this♥♥[/quote]
Healthcare Family & Contact Home Providers Patients Us FAQs
CLINICAL TRIAL FINDER The purpose of this Phase II/III study is to evaluate the safety and efficacy of SM-88 in patients with metastatic pancreatic cancer whose disease has progressed or recurred after two lines of prior systemic therapy.
The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world’s toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve patient outcomes today and to double survival by 2020.
General Information NCT#: NCT03512756 Study ID: Tyme-88-Panc Trial Phase: Phase II